Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 67(13): 6155-62, 2007 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-17616672

RESUMO

Resistance to apoptosis is a critical feature of neoplastic cells. Galectin-1 is an endogenous carbohydrate-binding protein that induces death of leukemia and lymphoma cells, breast cancer cells, and the LNCaP prostate cancer cell line, but not other prostate cancer cell lines. To understand the mechanism of galectin-1 sensitivity of LNCaP cells compared with other prostate cancer cells, we characterized glycan ligands that are important for conferring galectin-1 sensitivity in these cells, and analyzed expression of glycosyltransferase genes in galectin-1-sensitive, prostate-specific antigen-positive (PSA(+)) LNCaP cells compared with a galectin-1-resistant PSA(-) LNCaP subclone. We identified one glycosyltransferase, core 2 N-acetylglucosaminyltransferase, which is down-regulated in galectin-1-resistant PSA(-) LNCaP cells compared with galectin-1-sensitive PSA(+) LNCaP cells. Intriguingly, this is the same glycosyltransferase required for galectin-1 susceptibility of T lymphoma cells, indicating that similar O-glycan ligands on different polypeptide backbones may be common death trigger receptors recognized by galectin-1 on different types of cancer cells. Blocking O-glycan elongation by expressing alpha2,3-sialyltransferase 1 rendered LNCaP cells resistant to galectin-1, showing that specific O-glycans are critical for galectin-1 susceptibility. Loss of galectin-1 susceptibility and synthesis of endogenous galectin-1 has been proposed to promote tumor evasion of immune attack; we found that galectin-1-expressing prostate cancer cells killed bound T cells, whereas LNCaP cells that do not express galectin-1 did not kill T cells. Resistance to galectin-1-induced apoptosis may directly contribute to the survival of prostate cancer cells as well as promote immune evasion by the tumor.


Assuntos
Apoptose , Galectina 1/biossíntese , Regulação Neoplásica da Expressão Gênica , Glicosilação , Antígeno Prostático Específico/biossíntese , Neoplasias da Próstata/metabolismo , Linhagem Celular Tumoral , Citometria de Fluxo , Humanos , Linfoma de Células T/metabolismo , Masculino , Modelos Biológicos , Invasividade Neoplásica , Polissacarídeos/metabolismo , Linfócitos T/metabolismo
2.
J Immunol ; 175(1): 413-20, 2005 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-15972675

RESUMO

Galectin-1 (gal-1), an endogenous lectin secreted by a variety of cell types, has pleiotropic immunomodulatory functions, including regulation of lymphocyte survival and cytokine secretion in autoimmune, transplant disease, and parasitic infection models. However, the role of gal-1 in viral infections is unknown. Nipah virus (NiV) is an emerging pathogen that causes severe, often fatal, febrile encephalitis. The primary targets of NiV are endothelial cells. NiV infection of endothelial cells results in cell-cell fusion and syncytia formation triggered by the fusion (F) and attachment (G) envelope glycoproteins of NiV that bear glycan structures recognized by gal-1. In the present study, we report that NiV envelope-mediated cell-cell fusion is blocked by gal-1. This inhibition is specific to the Paramyxoviridae family because gal-1 did not inhibit fusion triggered by envelope glycoproteins of other viruses, including two retroviruses and a pox virus, but inhibited fusion triggered by envelope glycoproteins of the related Hendra virus and another paramyxovirus. The physiologic dimeric form of gal-1 is required for fusion inhibition because a monomeric gal-1 mutant had no inhibitory effect on cell fusion. gal-1 binds to specific N-glycans on NiV glycoproteins and aberrantly oligomerizes NiV-F and NiV-G, indicating a mechanism for fusion inhibition. gal-1 also increases dendritic cell production of proinflammatory cytokines such as IL-6, known to be protective in the setting of other viral diseases such as Ebola infections. Thus, gal-1 may have direct antiviral effects and may also augment the innate immune response against this emerging pathogen.


Assuntos
Células Dendríticas/imunologia , Galectina 1/imunologia , Imunidade Inata , Vírus Nipah/imunologia , Vírus Nipah/patogenicidade , Proteínas do Envelope Viral/fisiologia , Sítios de Ligação , Fusão Celular , Linhagem Celular , Citocinas/biossíntese , Encefalite Viral/imunologia , Galectina 1/genética , Galectina 1/fisiologia , Glicosilação , Infecções por Henipavirus/imunologia , Humanos , Mediadores da Inflamação/metabolismo , Vírus Nipah/fisiologia , Polissacarídeos/química , Polissacarídeos/metabolismo , Proteínas do Envelope Viral/química , Proteínas Virais de Fusão/química , Proteínas Virais de Fusão/fisiologia
4.
J Biol Chem ; 277(15): 13091-8, 2002 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-11809773

RESUMO

We have cloned and characterized the first galectin to be identified in Drosophila melanogaster. The amino acid sequence of Drosophila galectin showed striking sequence similarity to invertebrate and vertebrate galectins and contained amino acids that are crucial for binding beta-galactoside sugars. Confirming its identity as a galectin family member, the Drosophila galectin bound beta-galactoside sugars. Structurally, the Drosophila galectin was a tandem repeat galectin containing two carbohydrate recognition domains connected by a unique peptide link. This divalent structure suggests that like mammalian galectins, Drosophila galectin may mediate cell-cell communication or facilitate cross-linking of receptors to trigger signal transduction events. The Drosophila galectin was very abundant in embryonic, larval, and adult Drosophila. During embryogenesis, Drosophila galectin had a unique and specific tissue distribution. Drosophila galectin expression was concentrated in somatic and visceral musculature and in the central nervous system. Similar to other insect lectins, Drosophila galectin may function in both embryogenesis and in host defense. Drosophila galectin was expressed by hemocytes, circulating phagocytic cells, suggesting a role for Drosophila galectin in the innate immune system.


Assuntos
Drosophila melanogaster/crescimento & desenvolvimento , Galectinas , Lectinas/genética , Sequência de Aminoácidos , Animais , DNA Complementar , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Lectinas/química , Lectinas/metabolismo , Dados de Sequência Molecular , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Homologia de Sequência de Aminoácidos
5.
Glycoconj J ; 19(7-9): 607-14, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-14758086

RESUMO

As evidenced by the reviews in this special issue of Glycoconjugate Journal, much research is focused on determining functions for mammalian galectins. However, the identification of precise functions for mammalian galectins may be complicated by redundancy in tissue expression and in target cell recognition of the many mammalian galectins. Therefore, lower organisms may be useful in deciphering precise functions for galectins. Unfortunately, some genetically manipulable model systems such as Caenorhabditis elegans may have more galectins than mammals. Recently, galectins were identified in two well-studied insect systems, Drosophila melanogaster and Anopheles gambiae. In addition to the powerful genetic manipulation available in these insect models, there is a sophisticated understanding of many biological processes in these organisms that can be directly compared and applied to mammalian systems. Understanding the roles of galectins in insects may provide insight into precise functions of galectins in mammals.


Assuntos
Galectinas/metabolismo , Insetos/crescimento & desenvolvimento , Insetos/imunologia , Animais , Anopheles , Drosophila melanogaster , Embrião não Mamífero/citologia , Embrião não Mamífero/metabolismo , Galectinas/química , Insetos/embriologia , Insetos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...